As of 12/31/2024(updated quarterly, upon availability)
| Security Name | Asset Type | Company/Issuer | Shares or Principal Amount |
Market Value | Percent of Net Assets |
| Meta Platforms, Inc., Class A | Equity | Meta Platforms | 9,135,068 | $5,348,673,665.00 | 3.76% |
| Broadcom, Inc. | Equity | Broadcom | 21,446,959 | $4,972,262,975.00 | 3.50% |
| Microsoft Corp. | Equity | Microsoft | 11,380,973 | $4,797,080,120.00 | 3.37% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | Equity | TSMC | 143,895,941 | $4,698,707,884.00 | 3.30% |
| Tesla, Inc. | Equity | Tesla Inc | 11,207,138 | $4,525,890,610.00 | 3.18% |
| Capital Group Central Cash Fund | Short Term | | 37,343,942 | $3,735,141,093.00 | 2.63% |
| NVIDIA Corp. | Equity | NVIDIA | 25,030,337 | $3,361,323,956.00 | 2.36% |
| Novo Nordisk AS, Class B | Equity | Novo Nordisk | 31,370,601 | $2,699,980,944.00 | 1.90% |
| Netflix, Inc. | Equity | Netflix | 2,538,578 | $2,262,685,343.00 | 1.59% |
| Amazon.com, Inc. | Equity | Amazon.com | 9,646,378 | $2,116,318,869.00 | 1.49% |
| Eli Lilly and Co. | Equity | Eli Lilly | 2,525,205 | $1,949,458,260.00 | 1.37% |
| EssilorLuxottica SA | Equity | EssilorLuxottica | 7,256,657 | $1,763,360,815.00 | 1.24% |
| AstraZeneca PLC | Equity | AstraZeneca | 12,648,126 | $1,646,463,896.00 | 1.16% |
| Vertex Pharmaceuticals, Inc. | Equity | Vertex Pharmaceuticals | 4,030,115 | $1,622,927,311.00 | 1.14% |
| JPMorgan Chase & Co. | Equity | JPMorgan Chase | 6,670,333 | $1,598,945,523.00 | 1.12% |
| Company/Issuer | Security Name | Asset Type | Shares or Principal Amount |
Market Value | Percent of Net Assets |
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.
Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.
Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility. These risks may be heightened in connection with investments in developing countries.
All Capital Group trademarks mentioned are owned by The Capital Group Companies, Inc., an affiliated company or fund. All other company and product names mentioned are the property of their respective companies.
Portfolios are managed, so holdings will change. Certain fixed income and/or cash and equivalents holdings may be held through mutual funds managed by the investment adviser or its affiliates that are not offered to the public.
Totals may not reconcile due to rounding.
Use of this website is intended for U.S. residents only.
Capital Client Group, Inc.
This content, developed by Capital Group, home of American Funds, should not be used as a primary basis for investment decisions and is not intended to serve as impartial investment or fiduciary advice.